| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ramaswamy Vivek | 12% | +3.9% | $913,351,307 | +$11.01 | 82,956,522 | +0% | Ramaswamy Vivek | 31 Mar 2025 |
| FMR LLC | 8.2% | $602,830,791 | 55,509,281 | FMR LLC | 30 Jun 2025 | |||
| SB INVESTMENT ADVISERS (UK) LTD | 5.8% | -30% | $609,967,872 | -$328,962,663 | 40,315,127 | -35% | SB Investment Advisers (UK) Limited | 30 Sep 2025 |
| MORGAN STANLEY | 5.5% | $408,842,901 | 37,646,676 | Morgan Stanley | 30 Jun 2025 | |||
| QVT Financial LP | 4.3% | -55% | $319,084,556 | -$395,435,884 | 29,381,635 | -55% | QVT Financial LP | 30 Jun 2025 |
| VIKING GLOBAL INVESTORS LP | 3.4% | -32% | $356,989,793 | -$161,027,803 | 23,594,831 | -31% | VIKING GLOBAL INVESTORS LP | 30 Sep 2025 |
As of 30 Sep 2025, 332 institutional investors reported holding 501,588,936 shares of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV). This represents 72% of the company’s total 695,088,397 outstanding shares.
The largest institutional shareholders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) together control 59% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 8.7% | 60,766,984 | +9.5% | 0.05% | $919,404,470 |
| MORGAN STANLEY | 6.4% | 44,322,857 | -0.83% | 0.04% | $670,604,841 |
| SB INVESTMENT ADVISERS (UK) LTD | 5.8% | 40,315,127 | -33% | 4.6% | $609,967,872 |
| BlackRock, Inc. | 5.7% | 39,724,879 | -1.5% | 0.01% | $601,037,405 |
| VANGUARD GROUP INC | 5.6% | 38,804,928 | -1.3% | 0.01% | $587,118,561 |
| QVT Financial LP | 4.2% | 29,381,635 | 0% | 49% | $444,544,138 |
| VIKING GLOBAL INVESTORS LP | 3.4% | 23,594,831 | -31% | 0.93% | $356,989,793 |
| Rubric Capital Management LP | 2.9% | 20,000,000 | -1.8% | 4.1% | $302,600,000 |
| STATE STREET CORP | 2.7% | 18,700,144 | -5.4% | 0.01% | $282,933,179 |
| Patient Square Capital LP | 1.8% | 12,480,000 | 0% | 51% | $188,822,400 |
| Two Seas Capital LP | 1.7% | 11,754,164 | +11% | 11% | $177,840,501 |
| DIMENSIONAL FUND ADVISORS LP | 1.3% | 9,308,710 | +18% | 0.03% | $140,839,135 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2% | 8,202,594 | +5.8% | 0.01% | $124,128,691 |
| PERCEPTIVE ADVISORS LLC | 1.1% | 7,368,461 | +121% | 3.3% | $111,484,815 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1% | 7,232,383 | +247% | 0.17% | $109,425,955 |
| Bank of New York Mellon Corp | 0.67% | 4,630,948 | +2.8% | 0.01% | $70,066,244 |
| BlackBarn Capital Partners LP | 0.63% | 4,400,000 | -4.9% | 22% | $66,572,000 |
| STEMPOINT CAPITAL LP | 0.6% | 4,197,187 | +597% | 13% | $63,503,439 |
| MARSHALL WACE, LLP | 0.57% | 3,978,001 | +316% | 0.07% | $60,187,155 |
| BAKER BROS. ADVISORS LP | 0.54% | 3,767,773 | 0% | 0.41% | $57,006,405 |
| Whitefort Capital Management, LP | 0.51% | 3,532,000 | -9% | 18% | $53,439,160 |
| ADAR1 Capital Management, LLC | 0.48% | 3,347,501 | +72% | 5.1% | $50,647,690 |
| NORTHERN TRUST CORP | 0.47% | 3,283,061 | +1.5% | 0.01% | $49,672,712 |
| Sofinnova Investments, Inc. | 0.45% | 3,149,270 | +2% | 2.9% | $47,648,455 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.45% | 3,117,731 | +7.9% | 0.01% | $47,171,270 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 7,105,101 | $154,182,829 | +$149,009,498 | $21.70 | 13 |
| 2025 Q3 | 501,588,936 | $7,588,882,254 | -$163,254,242 | $15.13 | 332 |
| 2025 Q2 | 514,772,354 | $5,801,411,223 | -$418,510,172 | $11.27 | 337 |
| 2025 Q1 | 553,328,719 | $5,583,781,669 | -$111,475,682 | $10.09 | 310 |
| 2024 Q4 | 562,446,665 | $6,653,171,538 | -$86,396,710 | $11.83 | 312 |
| 2024 Q3 | 569,136,749 | $6,567,461,922 | +$223,573,966 | $11.54 | 291 |
| 2024 Q2 | 546,001,457 | $5,771,073,920 | +$151,629,366 | $10.57 | 293 |
| 2024 Q1 | 531,561,894 | $5,603,149,203 | -$165,817,358 | $10.54 | 258 |
| 2023 Q4 | 541,631,584 | $6,081,436,620 | -$171,734,221 | $11.23 | 223 |
| 2023 Q3 | 545,872,779 | $6,375,349,918 | +$537,705,852 | $11.68 | 205 |
| 2023 Q2 | 497,346,775 | $5,012,967,398 | +$397,737,203 | $10.08 | 178 |
| 2023 Q1 | 459,356,125 | $3,389,932,964 | +$349,480,110 | $7.38 | 144 |
| 2022 Q4 | 411,727,361 | $3,289,525,255 | +$291,883,961 | $7.99 | 107 |
| 2022 Q3 | 370,512,297 | $1,192,938,093 | +$30,768,202 | $3.22 | 75 |
| 2022 Q2 | 360,483,554 | $1,467,028,314 | +$45,607,814 | $4.07 | 71 |
| 2022 Q1 | 349,161,599 | $1,724,680,470 | +$48,168,384 | $4.94 | 50 |
| 2021 Q4 | 339,213,133 | $3,416,732,000 | +$3,374,253,000 | $10.08 | 40 |